OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis
Federica Novarella, Antonio Carotenuto, Paolo Cipullo, et al.
Toxins (2022) Vol. 14, Iss. 11, pp. 774-774
Open Access | Times Cited: 7
Federica Novarella, Antonio Carotenuto, Paolo Cipullo, et al.
Toxins (2022) Vol. 14, Iss. 11, pp. 774-774
Open Access | Times Cited: 7
Showing 7 citing articles:
Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: An observational longitudinal study
Alessio Baricich, Marco Battaglia, Daria Cuneo, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 15
Alessio Baricich, Marco Battaglia, Daria Cuneo, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 15
Botulinum Toxin Therapy: A Comprehensive Review on Clinical and Pharmacological Insights
Nahla Ayoub
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 2021-2021
Open Access
Nahla Ayoub
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 2021-2021
Open Access
Trends in Botulinum Toxin Use among Patients with Multiple Sclerosis: A Population-Based Study
Djamel Bensmaïl, Pierre Karam, Anne Forestier, et al.
Toxins (2023) Vol. 15, Iss. 4, pp. 280-280
Open Access | Times Cited: 10
Djamel Bensmaïl, Pierre Karam, Anne Forestier, et al.
Toxins (2023) Vol. 15, Iss. 4, pp. 280-280
Open Access | Times Cited: 10
Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine
Dilara Onan, Fatemeh Farham, Paolo Martelletti
Toxins (2024) Vol. 16, Iss. 7, pp. 309-309
Open Access | Times Cited: 3
Dilara Onan, Fatemeh Farham, Paolo Martelletti
Toxins (2024) Vol. 16, Iss. 7, pp. 309-309
Open Access | Times Cited: 3
An overview on disease modifying and symptomatic drug treatments for multiple sclerosis
Gloria Dalla Costa, Letizia Leocani, Mariaemma Rodegher, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 10, pp. 901-921
Closed Access | Times Cited: 1
Gloria Dalla Costa, Letizia Leocani, Mariaemma Rodegher, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 10, pp. 901-921
Closed Access | Times Cited: 1
Botulinum Toxin Treatment in Multiple Sclerosis
Bahman Jabbari
Springer eBooks (2024), pp. 101-117
Closed Access
Bahman Jabbari
Springer eBooks (2024), pp. 101-117
Closed Access
Effectiveness of repeated injections of botulinum toxin A on gait and fatigue in adults with spastic paraparesis secondary to multiple sclerosis
Aránzazu Vázquez-Doce, Laura García Delgado, María José Arriaza Gómez, et al.
Neurorehabilitation (2024) Vol. 54, Iss. 4, pp. 663-675
Closed Access
Aránzazu Vázquez-Doce, Laura García Delgado, María José Arriaza Gómez, et al.
Neurorehabilitation (2024) Vol. 54, Iss. 4, pp. 663-675
Closed Access
